Mirae Asset Global Etfs Holdings Ltd. Protara Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,635 shares of TARA stock, worth $87,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,635Holding current value
$87,469% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
81Shares Held
27.7MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$20.3 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$10.6 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$9.47 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$8.94 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$8.69 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $55.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...